Bicatero 50mg Tablet

Bicatero 50mg Tablet

Prescription requiredRx Required

Salt Composition: Bicalutamide

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

1x10 Tablets

About The Product

Prostate Cancer

Bicatero 50mg tablet is an anti-cancer drug that works by blocking the effect of the natural male hormones (testosterone) on the growth of prostate cells. This stops the tumor from growing and spreading and also leads to the reduction of its size. Bicatero 50mg tablet is also used in combination therapy with radiotherapy or prostate surgery in the early stages of the treatment. It should be taken at a fixed time every day with or without food.

Uses

Treatment of Prostate cancer

Side Effects

Most side effects caused by the Bicatero 50mg tablet don't require medical attention and may vanish upon your adjustment to the medicine. Consult your doctor immediately if you're unable to deal with these symptoms or if they persist.

  • Decreased appetite
  • Dizziness Nocturia (increased urge to urinate during the night)
  • Edema (swelling)
  • Anemia (low number of red blood cells)
  • Rash
  • Hot flashes
  • Nausea
  • Weaknes Abdominal pain
  • Constipation

How To Use

  • ​Take the Bicatero 50mg tablet as prescribed by your health professional.
  • Ensure you take this cancer-fighting formulation in the same amount as directed by your physician.
  • In case of an overdose, the patient is advised to consult a general practitioner as soon as possible if any unusual symptoms occur.
  • Bicatero 50mg tablet should be swallowed as a whole.
  • Let your doctor know if you have liver, thyroid, kidney disease, etc, or are on some other medications.
  • Bicatero 50mg tablet is not recommended for pregnant and breastfeeding women.

How It Works

Bicatero 50mg tablet functions by decreasing the effect of testosterone (male hormone) in the body. It does this by blocking the action of testosterone at specific sites, which slows down or prevents hormone-related changes in the human body.

As a result, certain cells or tissues may be affected.

Safety Advice

Alcohol

The interaction of alcohol with this drug is still unknown. It is advisable not to consume alcohol while taking Bicatero 50mg Tablet. Consult your doctor for further information.

Pregnancy

Bicatero 50mg Tablet may be considered unsafe during pregnancy. Please consult your doctor in such a condition. According to some research data, taking Bicatero 50mg Tablet during pregnancy has shown harmful effects on the developing baby.

Breast Feeding

Bicatero 50mg Tablet is probably not safe if you're breastfeeding. Kindly consult your doctor before taking Bicatero 50mg Tablet while breastfeeding, as there are chances that it may pass to the developing baby through the breast milk of the mother.

Driving

It is advisable not to drive or operate heavy machinery after taking Bicatero 50mg Tablet, as you may feel dizzy.

Kidney

Share your medical history with your healthcare expert in case of kidney disease before taking Bicatero 50mg Tablet. Patients with renal impairment must be careful while taking Bicatero 50mg Tablet. They may require adjustment in the dose.

Liver

Inform your doctor before starting Bicatero 50mg Tablet if you have liver disease to avoid any serious side effects. Patients with hepatic impairment must be careful while taking Bicatero 50mg Tablet. They may require adjustment in the dose.

Missed Doses

It is advisable to avoid missing any dose of Bicalutamide 50mg however in case you missed a dose consult your doctor immediately.

FAQs

Prostate cancer is treated with Bicatero 50mg tablet.


Reference

  1. Bilusic M, Toney NJ, Donahue RN, Wroblewski S, Zibelman M, Ghatalia P, Ross EA, Karzai F, Madan RA, Dahut WL, Gulley JL, Schlom J, Plimack ER, Geynisman DM. (2023). A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1). Prostate Cancer Prostatic Dis. 25(4):735-740. Epub.
  2. Furr BJ, Tucker H. (2022). The preclinical development of bicalutamide: pharmacodynamics and mechanism of action. Urology. 1996 Jan;47(1A Suppl):13-25; discussion 29-32 - https://pubmed.ncbi.nlm.nih.gov/8560673/
  3. Furr BJ. (2025). The development of Casodex (bicalutamide): preclinical studies. Eur Urol. 1996;29 Suppl 2:83-95 - https://pubmed.ncbi.nlm.nih.gov/8717469/
  4. Kotake T, Usami M, Isaka S, Shimazaki J, Nakano E, Okuyama A, Okajima E, Kanetake H, Saitoh Y, Kumamoto Y, Orikasa S, Sakata Y, Hosaka M, Akaza H, Koiso K, Honma Y, Aso Y, Oishi K, Yoshida O, Naitoh S, Kumazawa J, Koyanagi T, Yachiku S, Shiraiwa Y, Tsukagoshi S. (2025). [Clinical early phase II study of bicalutamide (Casodex) in patients with prostatic cancer]. Hinyokika Kiyo.42(2):157-68. Japanese - https://pubmed.ncbi.nlm.nih.gov/8712092/
  5. Lee S, Yoon SH, Cho JY, Shin SG, Jang IJ, Yu KS. (2024). Relative bioavailability and tolerability of two formulations of bicalutamide 50-mg tablets: a randomized-sequence, open-label, two-period crossover study in healthy Korean male subjects. Clin Ther. 32(14):2496-501 - https://pubmed.ncbi.nlm.nih.gov/21353117/
  6. Marijo Bilusic et al. (2023). Bicalutamide with or without metformin for biochemical recurrence in prostate cancer patients (BIMET-1). JCO 38, 85-85(2020) - https://ascopubs.org/doi/10.1200/JCO.2020.38.6_suppl.85
  7. Qian SB, Shen HB, Cao QF, Zhang L, Chen YF, Qi J. (2025). Bicalutamide 150 mg as secondary hormonal therapy for castration-resistant prostate cancer. Int Urol Nephrol. 47(3):479-84.
  8. Soloway MS, Schellhammer PF, Smith JA Jr, Chodak GW, Vogelzang NJ, Kennealey GT. (2024). Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II noncomparative multicenter trial evaluating safety, efficacy, and long-term endocrine effects of monotherapy. J Urol. 154(6):2110-4.
  9. Soloway MS, Schellhammer PF, Smith JA, Chodak GW, Kennealey GT. (2024). Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II multicenter trial. Urology. (1A Suppl):33-7; discussion 48-53.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Magicine PharmacopyCopyright 2026